IPP Bureau
Strides and Orbicular enter into a strategic partnership to develop a range of nasal sprays
By IPP Bureau - May 04, 2023
The partnership will commercialize four nasal sprays with a combined Global IQVIA market size in excess of $400m
AstraZeneca Pharma India receives permission for sale and distribution of Trastuzumab deruxtecan
By IPP Bureau - May 04, 2023
The receipt of this permission paves way for the launch of Trastuzumab deruxtecan (Enhertu) solution of 100mg/5mL in India
Indoco receives EIR for its Plant I manufacturing facility in Goa
By IPP Bureau - May 04, 2023
Indoco expects this change in compliance status to pave the way for approvals of ANDAs submitted from this site.
USFDA puts on hold Sun Pharma trials on dermatological drug
By IPP Bureau - May 04, 2023
Sun Pharma said had a teleconference call with the US Food and Drug Administration (USFDA) regarding a pulmonary embolism (serious adverse events) occurring at the 12 mg dose
Mandaviya reviews organ donation policy
By IPP Bureau - May 04, 2023
Organ Transplants triple across the country; rise from 5000 (2013) to more than 15000 in 2022
Astec LifeSciences appoints K. Suryanarayan as Chief Financial Officer
By IPP Bureau - May 04, 2023
He has over two decades of leadership experience as an innovative strategic planner in finance diligence
Astec LifeSciences FY23 PAT declines to Rs. 25.6 Cr
By IPP Bureau - May 03, 2023
The consolidated EBITDA stood at Rs. 89.3 crore in FY23 as compared to Rs. 164.5 crore in the same period last year
Laurus Labs receives USFDA tentative approval for Dolutegravir 5mg and 10mg in HIV/AIDS treatment
By IPP Bureau - May 03, 2023
It will help in bringing a significant benefit in compliance of ARV medication in the paediatric HIV treatment
USFDA Advisory Committee votes n Lynparza plus Abiraterone and Prednisone for prostate cancer
By IPP Bureau - May 03, 2023
The committee voted that FDA should restrict use of LYNPARZA plus abi/pred to these BRCAm mCRPC patients
IMCD Colombia acquires pharma API distributor Allianz
By IPP Bureau - May 03, 2023
Allianz is ISO 9001:2015 certified and INVIMA certified for storage, sampling, dispensation, and distribution of APIs to the Colombian market
CPHI & PMEC China 2023 to see surge from pent up international ingredients demand
By IPP Bureau - May 03, 2023
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
Healthium Medtech appoints Prashant Krishnan as Global Business Head for Advanced Wound Care and Surgery
By IPP Bureau - May 02, 2023
The strategic appointment is also critical to reinforcing Healthium’s market leadership, corporate governance and deep domain expertis
Majority of UK physicians believe Brexit aggravated NHS staff shortage crisis: GlobalData
By IPP Bureau - May 02, 2023
Brexit had a negative impact on NHS staff shortages and worsened the workforce crisis
Lilly's Lebrikizumab shows improved face or hand dermatitis
By IPP Bureau - May 02, 2023
Lebrikizumab is an investigational high-affinity and potent IL-13 inhibitor being studied in adult and adolescent patients
CHMP recommends EU approval of Roche’s fixed-duration Columvi for large B-cell lymphoma
By IPP Bureau - May 02, 2023
Once approved, Columvi will be the first CD20xCD3 T-cell-engaging bispecific antibody available to treat people in Europe with this aggressive lymphoma
